YSB Inc.
Research YSB Inc. (9885.HK) on Bullrun: market cap HKD 2.33B, P/E 11.3, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker9885.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyHKD
- Market capHKD 2.33B
- P/E11.3
- Dividend yield3.7%
- Financial periodFY2025
- RevenueCNY 20.97B
- Revenue growth17.1%
- Net incomeCNY 152.97M
- Free cash flowCNY 619.46M
- Gross margin11.0%
Valuation Snapshot
latest market cap is HKD 2.33B; P/E is 11.3; dividend yield is 3.7%.
Peer valuation comparison
Latest P/E is 11.32x versus a Healthcare sector median of 21.69x (47.8% below).
Latest dividend yield is 3.68% versus a Healthcare sector median of 2.41% (52.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 20.97B | CNY 152.97M | CNY 619.46M | 11.0% | 0.22 | CNY 706.87M | CNY 327.45M | CNY 2.44B |
| FY2024 | CNY 17.90B | CNY 30.01M | CNY 632.46M | 10.1% | 0.05 | CNY 1.01B | CNY 233.51M | CNY 2.32B |
| FY2023 | CNY 16.97B | -CNY 3.21B | CNY 433.65M | 10.3% | -8.26 | CNY 673.87M | CNY 209.66M | CNY 1.92B |
| FY2022 | CNY 14.27B | -CNY 1.50B | CNY 54.49M | 10.1% | -2.37 | CNY 835.39M | CNY 180.55M | -CNY 4.35B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 2.33B | 11.3 | 3.7% | 0.13 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.13 HKD, yield 3.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.08 CNY |
About YSB Inc.
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is YSB Inc.'s market cap?
YSB Inc.'s market capitalization is HKD 2.33B.
What is YSB Inc.'s P/E ratio?
YSB Inc.'s price-to-earnings (P/E) ratio is 11.3.
Does YSB Inc. pay a dividend?
YSB Inc. has a dividend yield of 3.7%.
What does YSB Inc. do?
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations.